Transforming the delivery of paediatric therapeutics through collaboration
Wednesday 04 February 2026
Jess McNeill
In collaboration with Vesynta, the NIHR HRC PCH team recently led a series of workshops with specialist healthcare professionals to improve an innovative precision dosing tool, DosoLogic.
Treatment for children and young people diagnosed with diseases such as cancer can be a long and difficult experience, and it often requires multiple doses of various therapeutics over time. Calculating the right dose is a complex process to ensure patients benefit from the treatment without suffering unnecessary and unpleasant side effects. DosoLogic (developed by Vesynta) is a tool that helps clinicians determine a more accurate dose of therapeutics by collating clinical data to develop a personalised, precise therapeutic dose based on the individual’s needs.
Creating healthcare solutions that centre the needs of the user is a key priority at the NIHR HRC in Paediatrics and Child Health (NIHR HRC PCH). While many of the health technologies we help develop are designed to be used by young people and families at home, we also support innovations that fit into the care pathway earlier on that help healthcare professionals deliver better care to their patients while they’re in hospital. For a new health technology solution to be accepted into clinical practice and usable for clinicians and hospital staff, communication with multi-disciplinary teams is vital throughout the development journey.
In collaboration with Vesynta, the NIHR HRC PCH team recently organised a series of workshops that brought together clinical prescribers and hospital staff from several departments within Sheffield Children’s. These workshops invited honest feedback and input about the design and usability of DosoLogic from a staff perspective, and facilitated discussions about what the participants felt was needed in order for it to be successfully and sustainably implemented into practice.
What were the key outcomes of the workshops?
These workshops explored the validity of this unmet need in the care pathway and ultimately led to a greater understanding of the staff’s needs and how DosoLogic can be improved to ensure successful adoption into the current healthcare system. This stakeholder engagement will enable Vesynta to adapt their innovation and ensure it meets the needs of the users.
Key findings of the sessions include:
- A greater understanding of the day-to-day roles, responsibilities, and challenges faced by the clinical prescribing teams
- Mapping out how this technology could change the way staff operate and the overall impact it could have on patients
- Identification of potential barriers to bringing DosoLogic into practice and ideas to overcome them
- Key areas of improvement to enhance the reliability and usability of the tool that Vesynta can action
- Participants were engaged throughout, responded positively to being involved in the process, and expressed interest in attending future workshops
- A clear summary of next steps that will improve the system was laid out and will present an opportunity to invite participants back to evaluate the updated version of DosoLogic
Emma Moffat, Project Manager for the Long-Term Conditions in Childhood and Transition Themes, led on the organisation and delivery of the workshops for staff in Sheffield Children’s.
“It was great revisiting some of the connections I’d made in my previous roles at Sheffield Children’s, and to give them the opportunity to adapt a technology that they could end up using everyday, was very rewarding.”
Emma Moffat
Project Manager for the Long-Term Conditions in Childhood and Transition Themes, NIHR HRC PCH
It has been a pleasure to work alongside Dr Jugal Suthar, Co-founder and CEO, and Dr Alaric Taylor, Co-founder and CTO, at Vesynta, and we look forward to continuing this fantastic collaboration.
For more information about Dosologic, please visit the Vesynta website using the link below.
This work was supported by UK Research and Innovation (UKRI) – Innovate UK.
